The costing projections we have been asked to put together have focused purely on what the operational costs would be of additional cell space. I take your point that there are some other competing costs that get factored into the equation when you look at it at a higher level. That's not something we've costed, but it's something for this committee to consider in the course of deliberating on this bill.
